Article Information
History
- May 17, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ute Jungwirth1,2,
- Antoinette van Weverwijk1,3,
- Liam Jenkins1,
- John Alexander1,
- David Vicente1,
- Qiong Gao1,
- Syed Haider1,
- Marjan Iravani1 and
- Clare M. Isacke1,*
- 1The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK
- 2Department of Pharmacy and Pharmacology, Centre for Therapeutic Innovation, University of Bath, Bath BA2 7AY, UK
- 3Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
- 4Strategic Initiatives, Data Science, The Institute of Cancer Research, Sutton SM2 5NG, UK
- ↵*Corresponding Author:
Clare M. Isacke, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK. Tel: +44 20 7153 5510; Fax: +44 20 7153 5340; Email: clare.isacke{at}icr.ac.uk